Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
Clinical trial NCT03310372 · COMPLETED
Trial details
- NCT number
- NCT03310372
- Sponsor
- Central Hospital, Nancy, France
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-13
- Primary completion
- 2012-06-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.